SEC Form 4 · accession 0001493152-26-044207
IMPACT BIOMEDICAL INC. · IBO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
DSS, INC.
10% Owner
Period of report
Sep 22, 2026
Accepted (ET)
Sep 24, 2026 · 7:37 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001834105
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 22, 2026 | S | 723 | $0.55 | D | 589,701 | D | |
| Common Stock | Sep 23, 2026 | S | 27 | $6.95 | D | 589,674 | D | |
| Common Stock | Sep 24, 2026 | S | 156 | $7.0587 | D | 589,518 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
This entity is a wholly-owned subsidiary of DSS, Inc.